Dexmedetomidine-esketamine combination
2024-234
Approved small_molecule active
Quick answer
Dexmedetomidine-esketamine combination for Obstructive Sleep Apnea is a Approved program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- Obstructive Sleep Apnea
- Phase
- Approved
- Modality
- small_molecule
- Status
- active